Citation Impact
Citing Papers
Ten things you should know about protein kinases: IUPHAR R eview 14
2015
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer
2017
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Breast cancer
2019 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Early skin-to-skin contact for mothers and their healthy newborn infants
2016 Standout
Enhancing Endocrine Therapy for Hormone Receptor–Positive Advanced Breast Cancer: Cotargeting Signaling Pathways
2015
Breast cancer
2016 Standout
Emerging strategies for TNBC with early clinical data: new chemoimmunotherapy strategies
2022
Prognostic Factors Predictive of Response and Survival to a Modified FOLFOX Regimen: Importance of an Increased Neutrophil Count
2006
Second international consensus guidelines for breast cancer in young women (BCY2)
2016
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2013
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)
2017
Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform
2016
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
2017 StandoutNobel
Sexual dysfunction and infertility as late effects of cancer treatment
2014
Widespread Translational Remodeling during Human Neuronal Differentiation
2017 StandoutNobel
Treatment for the endocrine resistant breast cancer: Current options and future perspectives
2017
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
People with cancer and their family caregivers’ personal experience of using supportive eHealth technology: A narrative review
2021
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Targeting the translation machinery in cancer
2015
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
2014
Palbociclib and Letrozole in Advanced Breast Cancer
2016 Standout
Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment
2022
The PI3K Pathway in Human Disease
2017 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
The effectiveness of e-Health interventions on caregiver burden, depression, and quality of life in informal caregivers of patients with cancer: A systematic review and meta-analysis of randomized controlled trials
2022 Standout
ABM Clinical Protocol #1: Guidelines for Blood Glucose Monitoring and Treatment of Hypoglycemia in Term and Late-Preterm Neonates, Revised 2014
2014
First international consensus guidelines for breast cancer in young women (BCY1)
2014
Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?
2018
Breast Cancer Statistics, 2022
2022 Standout
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
2014 Standout
Maintenance Therapy to Suppress Micrometastasis: The New Challenge for Adjuvant Cancer Treatment
2005
Breast Cancer Treatment
2019 Standout
Molecular Docking: Shifting Paradigms in Drug Discovery
2019 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
2016
Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers
2014
Cancer treatment and survivorship statistics, 2019
2019 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Works of Barbara Pistilli being referenced
Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis
2013
Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2
2013
Use of mHealth to Increase Physical Activity Among Breast Cancer Survivors With Fatigue: Qualitative Exploration
2021
Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy
2017
Predictors of Short-Term Survival and Progression to Chemotherapy in Patients With Advanced Colorectal Cancer Treated With 5-Fluorouracil-Based Regimens
2002
Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: How should we counsel cancer patients about breastfeeding?
2012
Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies
2017
Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial
2019
Prognostic Impact of Pregnancy After Breast Cancer According to Estrogen Receptor Status: A Multicenter Retrospective Study
2012